Loading clinical trials...
Loading clinical trials...
The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
NYU Langone Health
NCT07540260 · Radiation Therapy, Metastatic Renal Cancer, and more
NCT05969496 · Renal Cancer, Kidney Cancer, and more
NCT07123090 · Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, and more
NCT00026884 · Malignant Neoplasms, Hereditary Neoplastic Syndromes, and more
NCT05888532 · Prostate Cancer, Renal Cancer, and more
NYU Langone Health
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions